Importance and globalization status of good manufacturing practice (GMP) requirements for pharmaceutical excipients.
暂无分享,去创建一个
Mohamed Ibrahim Noordin | M. I. Noordin | Abubaker Abdellah | Wan Azman Wan Ismail | Abubaker Abdellah
[1] J. Abraham,et al. Globalization of Medicines Control , 2003 .
[2] P. Baldrick. Pharmaceutical excipient development: the need for preclinical guidance. , 2000, Regulatory toxicology and pharmacology : RTP.
[3] Michael J Akers,et al. Excipient-drug interactions in parenteral formulations. , 2002, Journal of pharmaceutical sciences.
[4] S. S. Kornblum,et al. A new tablet disintegrating agent: cross-linked polyvinylpyrrolidone. , 1973, Journal of pharmaceutical sciences.
[5] R. Osterberg,et al. Toxicity of Excipients—A Food and Drug Administration Perspective , 2003, International journal of toxicology.
[6] Gary T Chiang. CENTER FOR DRUG EVALUATION AND RESEARCH , 2010 .
[7] M. Steinberg,et al. From Inactive Ingredients to Pharmaceutical Excipients , 2001 .
[8] Thorsteinn Loftsson,et al. Cyclodextrins as pharmaceutical solubilizers. , 2007, Advanced drug delivery reviews.
[9] Pertti Alasuutari. Globalization and the Nation-State: An Appraisal of the Discussion , 2000 .
[10] Hui Xu,et al. Evaluation of hydroperoxides in common pharmaceutical excipients. , 2007, Journal of pharmaceutical sciences.
[11] B. Rumack,et al. Pharmaceutical Excipients , 1988 .
[12] T. Collins. Globalization, global health, and access to healthcare. , 2003, The International journal of health planning and management.
[13] D. Bindra,et al. Drug Excipient Interactions , 2015 .
[14] Georges Houin,et al. Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo. , 2004, International journal of pharmaceutics.
[15] Pant,et al. Drug-excipient interactions and their affect on absorption. , 2000, Pharmaceutical science & technology today.
[16] M. Gohel,et al. A review of co-processed directly compressible excipients. , 2005, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.
[17] G Pifferi,et al. Quality and functionality of excipients. , 1999, Farmaco.
[18] A. Awaisu,et al. A survey exploring knowledge and perceptions of general practitioners towards the use of generic medicines in the northern state of Malaysia. , 2010, Health policy.
[19] L. Illum,et al. Chitosan and its use as a pharmaceutical excipient. , 1998, Pharmaceutical research.
[20] M. Fujii,et al. Effect of N-methyl-2-pyrrolidone on skin permeation of estradiol. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[21] Thomson,et al. An overview of the different excipients useful for the direct compression of tablets. , 2000, Pharmaceutical science & technology today.
[22] S. Wolfgang,et al. The Effect of Globalization of Drug Manufacturing, Production, and Sourcing and Challenges for American Drug Safety , 2008, Clinical pharmacology and therapy.
[23] Patrizia Restani,et al. The safety of pharmaceutical excipients. , 2003, Farmaco.
[24] R. Strickley. Solubilizing Excipients in Oral and Injectable Formulations , 2004, Pharmaceutical Research.
[25] P. Baldrick. The safety of chitosan as a pharmaceutical excipient. , 2010, Regulatory toxicology and pharmacology : RTP.
[26] F. Monsuur,et al. Raising expectations of excipients , 2010 .